Sign in

CIK 0001817713

  • Large accelerated filer

Janux Therapeutics, Inc.

Sign in to watch
Ticker
JANX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
822289112
Phone
+1 858-751-4493
Business address
10955 VISTA SORRENTO PARKWAY, SUITE 200, SAN DIEGO, CA, 92130
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 38 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-06-26 Lichter Jay Director Grant or award · Stock Option (right to buy) +8,350 8,350
2024-06-26 McNulty Alana B. Director Grant or award +2,500 2,500
2024-06-26 McNulty Alana B. Director Grant or award · Stock Option (right to buy) +8,350 8,350
2024-06-26 Kung Winston Director Grant or award +2,500 2,500
2024-06-26 Kung Winston Director Grant or award · Stock Option (right to buy) +8,350 8,350
2024-06-26 Gujrathi Sheila Director Grant or award +2,500 110,528
2024-06-26 Gujrathi Sheila Director Grant or award · Stock Option (right to buy) +8,350 8,350
2024-06-26 Barrett Ronald W Director Grant or award +2,500 2,500
2024-06-26 Barrett Ronald W Director Grant or award · Stock Option (right to buy) +8,350 8,350
2024-06-26 Simson Jake Director Grant or award +2,500 2,500
2024-06-26 Simson Jake Director Grant or award · Stock Option (right to buy) +8,350 8,350
2024-06-26 CAPPS VICKIE L Director Grant or award +2,500 68,043
2024-06-26 CAPPS VICKIE L Director Grant or award · Stock Option (right to buy) +8,350 8,350
2024-06-03 Lichter Jay Director Sale −677,279 $54.75 $37.1M 3,271,216
2024-06-03 Lichter Jay Director Sale −131,196 $54.75 $7.2M 633,673
2024-06-03 Lichter Jay Director Sale −691,525 $54.75 $37.9M 3,340,018
2024-06-03 Reardon Tighe Acting Chief Financial Officer Sale −131,196 $54.75 $7.2M 633,673
2024-06-03 Reardon Tighe Acting Chief Financial Officer Sale −691,525 $54.75 $37.9M 3,340,018
2024-06-03 Avalon Ventures XI, L.P. 10% owner Sale −677,279 $54.75 $37.1M 3,271,216
2024-06-03 Avalon Ventures XI, L.P. 10% owner Sale −131,196 $54.75 $7.2M 633,673

Page 13 of 15 · 294 trades